vimarsana.com

Latest Breaking News On - Nfl biosciences - Page 1 : vimarsana.com

Nfl Biosciences: Patent Application Filed in the United

NFL BIOSCIENCES: PATENT APPLICATION FILED IN THE UNITED STATES FOR REDUCING ALCOHOL CONSUMPTION WITH NFL-301 & PREPARATION OF A PRE-IND APPLICATION.

United statesMclean hospitalAthena pharmaceutiquesScott lukasBruno lafontFrancis ahnerAgence calyptusBehavioral psychopharmacology research laboratoryDrug administrationEuronext growth parisMclean hospital imaging centerHarvard medical schoolChief operating officerPre investigational new drugParis stock exchange alnflNfl biosciences

NFL BIOSCIENCES: GB HOLDING TAKES A STAKE IN THE COMPANY S

NFL BIOSCIENCES: GB HOLDING TAKES A STAKE IN THE COMPANY’S CAPITAL UPON THE EXERCISE OF SHARE SUBSCRIPTION WARRANTS AND PAYMENT OF 0.5M€, AND ALSO COMMITS.

Bruno lafontIgnacio fausAgence calyptusGb holdingEuronext growth parisCentral nervous systemHospital injectablesInvest securitiesFinancial reportParis stock exchange alnflNfl biosciences

NFL Biosciences: 2022 full-year business and earnings

NFL Biosciences: 2022 full-year business and earnings update Phase II/III clinical trial for the drug candidate NFL-101 for smoking cessation: 100% of.

United statesClermont ferrandSouth koreaFrance generalPoitou charentesUnited arab emiratesIgnacio fausAgence calyptusInstitut pasteurBruno lafontEuropean medicines agencyHealth productsAtomic energy commissionClinical investigation centersFood drug administrationThemis medicare ltd

NFL Biosciences launches a round of fundraising for

NFL Biosciences launches a round of fundraising for approximately 2.5 million euros Capital increases as part of a global offer comprising an offer.

United statesIgnacio fausInstitut pasteurEuropean medicines agencyUs food drug administrationDrug administrationPrimarybid offerEuronext growth parisReserved offerExtraordinary general meetingParis stock exchange alnflNfl biosciences

NFL BIOSCIENCES: Decision to approve the issuing of its

NFL BIOSCIENCES: Decision to approve the issuing of its patent in South Korea NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a.

United statesUnited arab emiratesSaudi arabiaSouth koreaSouth koreanBruno lafontAgence calyptusEuronext growth parisChief operating officerParis stock exchange alnflNfl biosciences

vimarsana © 2020. All Rights Reserved.